Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2022 Earnings Call Transcript February 22, 2023
Operator: Good morning and welcome to Editas Medicine’s Fourth Quarter and Full-year 2022 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the Company’s request. I would now like to turn the call over to Ron Moldaver, Investor Relations for Editas Medicine.
Ron...
